El Futuro en el Tratamiento del Cáncer Renal - page 32

RO6874281 an anti-FAP-IL2v in RCC:

Engineered Immunoglobulin-cytokine fusion protein

Roche. Data on file

Sanchez-Garrrido M, et al. Mol Metab 2016

EUDRACT NUMBER: 2016-003528-22

Tumor target

Anti-FAP

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,22,23,24,25,26,27,28,29,30,31 33,34,35,36